Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™

Improved GI Tolerability with Monthly Ibandronate in Women Previously Using Weekly Bisphosphonates

(2011) Neil Binkley et al.   SOUTHERN MEDICAL JOURNAL

Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US™

(2010) A. N. A. Tosteson et al.   OSTEOPOROSIS INTERNATIONAL

Patient Satisfaction in Postmenopausal Women Treated with a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate

(2009) Sydney Lou Bonnick et al.   JOURNAL OF WOMENS HEALTH

Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass

(2009) D. L. Kendler et al.   OSTEOPOROSIS INTERNATIONAL

Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review

(2009) T. Gleeson et al.   OSTEOPOROSIS INTERNATIONAL

Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis

(2009) I. Imaz et al.   OSTEOPOROSIS INTERNATIONAL

Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice

(2009) Laurie J Pencille et al.   Trials

Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II)

(2008) Peyman Hadji et al.   JOINT BONE SPINE

Patient Decision to Initiate Therapy for Osteoporosis: The Influence of Knowledge and Beliefs

(2008) Robert A. Yood et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Design of the POSSIBLE US™ Study: postmenopausal women’s compliance and persistence with osteoporosis medications

(2008) E. Barrett-Connor et al.   OSTEOPOROSIS INTERNATIONAL

Preferences of patients receiving bisphosphonates – How to influence the therapeutic adherence

(2007) Juraj Payer et al.   BIOMEDICINE & PHARMACOTHERAPY